Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass

Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass

Dexcom G7 & Geofencing: Travel Alert If you are a Dexcom G7 user or using MDI with connection to phone app, PLEASE READ: you are planning travel shortly away from your home country, and you use open-source DIY app or MDI or Mobi or will use O5 with G7 Dexcom G7 is...
Savvy Updates 7/15/24:  Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay

Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work

Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work

Senseonics tips 365-day CGM to double 2025 sales by Nick Paul Taylor for MedTechDive.com, 25 June 2024. In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current...
Savvy Updates 6/24/24:  Dex G7/Apple Watch Integration with Jake Leach, Off-limits T1D Meds (GLP-1 & SGLT-2), Sequel Twiist Improves Occlusion Detection, SGLT-2/GRA Good Combo for T1D, FDA Commissioner on What’s Wrong with Diabetes Technology, Precision Medicine with Diamyd, Tandem Appoints Kyrillos as COO, CKD Linked to Tooth Loss After Menopause, Amazon RxPass Program, PMBs Driving Up Drug Costs

Savvy Updates 6/24/24: Dex G7/Apple Watch Integration with Jake Leach, Off-limits T1D Meds (GLP-1 & SGLT-2), Sequel Twiist Improves Occlusion Detection, SGLT-2/GRA Good Combo for T1D, FDA Commissioner on What’s Wrong with Diabetes Technology, Precision Medicine with Diamyd, Tandem Appoints Kyrillos as COO, CKD Linked to Tooth Loss After Menopause, Amazon RxPass Program, PMBs Driving Up Drug Costs

Interview with Dexcom COO Jake Leach about the Dexcom G7/Apple Watch Integration by Daniel Trecroci for BeyondType1.org, June 2024. Explore the innovative pairing of the Apple Watch and the Dexcom G7 continuous glucose monitoring (CGM) device.  In this...
Savvy Updates 6/17/24:  Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

Savvy Updates 6/17/24: Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

FDA approves Abbott’s Lingo and Libre Rio glucose monitoring systems by Archana Rani for MedicalDevice-Network.com, June 2024. The US Food and Drug Administration (FDA) has approved Abbott’s Lingo and Libre Rio over-the-counter continuous glucose monitoring (CGM)...
Savvy Updates 6/10/24:  Breakthrough T1D, Dexcom G7 Direct to Apple Watch, Tandem Diabetes Extended Wear Insulin Infusion Set Clinical Trial, Glucotrack Implantable CGM, Eating Veggies Improves Glucose Tolerance, Xylitol Increases Heart Attack Risk, Concierge Medicine

Savvy Updates 6/10/24: Breakthrough T1D, Dexcom G7 Direct to Apple Watch, Tandem Diabetes Extended Wear Insulin Infusion Set Clinical Trial, Glucotrack Implantable CGM, Eating Veggies Improves Glucose Tolerance, Xylitol Increases Heart Attack Risk, Concierge Medicine

JDRF Rebrands as Breakthrough T1D to Accelerate Type 1 Research and Advocacy by Daniel Trecroci for BeyondType1.org, 4 June 2024. On June 4, 2024, the Juvenile Diabetes Research Foundation (JDRF) announced that Breakthrough T1D was the new name for the...
Savvy Updates 6/3/24:  Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

The Modular Medical MODD1 insulin pump. What do we know? by Tim Street for Diabettech.com, 31 May 2024. Modular Medical recently submitted their new pump system to the FDA for approval. It’s described as: “Effortless Insulin Delivery Made Possible.”...
Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...
Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed

Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed

Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...
Skip to content